Skip to content
  1. Committee Activity
  2. Hearings
Full Committee

Examining the Implications of Drug Importation

Type: Full Committee Hearing
Date:
Time: 10:00am
Location: SH 216

Member Statements

Panel I

Panel II

  • Ms. Elizabeth G. Durant

    Executive Director Of Trade Compliance and Facilitation
    Office of Field Operations at the Bureau of Customs and Border Protection (CBP)

  • Mr. John Taylor III

    Associate Commissioner for Regulatory Affairs
    U.S. Food and Drug Administration

  • Mr. William K. Hubbard

    Associate Commissioner for Policy and Planning
    U.S. Food and Drug Administration
    Download Witness Testimony

Panel III

  • The Honorable Rudolph W. Giuliani

    Former Mayor of New York City
    Chairman and CEO, Giuliani Partners LLC
    Download Witness Testimony

  • Mr. Carmen A. Catizone, M.S., RPh, DPh

    Executive Director/Secretary
    National Association of Boards of Pharmacy Boards
    Download Witness Testimony

  • Ms. Joanna Disch, Ph.D.

    Board Member
    AARP
    Download Witness Testimony

  • Ms. Kathleen Jaeger

    President and CEO
    Generic Pharmaceutical Association
    Download Witness Testimony

  • Dr. Elizabeth A. Wennar M.P.H, D.H.A.

    President and CEO, United Health Alliance of Bennington, VT and Principal, HealthInova of MAnchester, VT
    United Health Alliance
    Download Member Statement

  • Professor Stephen W. Schondelmeyer, Ph.D.

    Professor of Pharmaceutical Economics
    University of Minnesota College of Pharmacy